Outlook Therapeutics (OTLK) has released an update to notify the public and investors about its financial commitment initiation.
The contents of Item 1.01 in the Current Report on Form 8-K are also applicable and included in Item 2.03, as they have been expressly incorporated by reference.
For further insights into OTLK financials, check out TipRanks’ Financials page.
